-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of lessee's right to use underlying asset under operating lease.
-
Summary
-
Ambrx Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2022 to Q3 2023.
- Ambrx Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2023 was $9.57M.
Operating Lease, Right-of-Use Asset, Quarterly (USD)